Annual report pursuant to Section 13 and 15(d)

EQUITY METHOD INVESTMENTS

v3.22.0.1
EQUITY METHOD INVESTMENTS
 12 Months Ended
Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]  
EQUITY METHOD INVESTMENTS EQUITY METHOD INVESTMENTS
Our consolidated net income includes our Company’s proportionate share of the net income or loss of our equity method investees. When we record our proportionate share of net income, it increases equity income (loss) — net in our consolidated statement of income and our carrying value of that investment. Conversely, when we record our proportionate share of a net loss, it decreases equity income (loss) — net in our consolidated statement of income and our carrying value of that investment. The Company’s proportionate share of the net income or loss of our equity method investees includes significant operating and nonoperating items recorded by our equity method investees. These items can have a significant impact on the amount of equity income (loss) — net in our consolidated statement of income and our carrying value of those investments. Refer to Note 17 for additional information related to significant operating and nonoperating items recorded by our equity method investees. The carrying values of our equity method investments are also impacted by our proportionate share of items impacting the equity method investees’ AOCI.
We eliminate from our financial results all significant intercompany transactions to the extent of our ownership interest, including the intercompany portion of transactions with equity method investees.
The Company’s equity method investments include, but are not limited to, our ownership interests in CCEP, Monster, AC Bebidas, S. de R.L. de C.V., Coca-Cola FEMSA, S.A.B. de C.V., Coca-Cola HBC AG and Coca-Cola Bottlers Japan Holdings Inc. (“CCBJHI”). As of December 31, 2021, we owned approximately 19 percent, 19 percent, 20 percent, 28 percent, 21 percent and 19 percent, respectively, of these companies’ outstanding shares. As of December 31, 2021, our investments in our equity method investees in the aggregate exceeded our proportionate share of the net assets of these equity method investees by $7,298 million. This difference is not amortized.
A summary of financial information for our equity method investees in the aggregate is as follows (in millions):
Year Ended December 31,1
2021 2020 2019
Net operating revenues $ 79,934  $ 69,384  $ 75,980 
Cost of goods sold 47,847  41,139  44,881 
Gross profit $ 32,087  $ 28,245  $ 31,099 
Operating income $ 9,089  $ 7,056  $ 7,748 
Consolidated net income $ 6,050  $ 4,176  $ 4,597 
Less: Net income attributable to noncontrolling interests 91  54  63 
Net income attributable to common shareowners $ 5,959  $ 4,122  $ 4,534 
Company equity income (loss) — net $ 1,438  $ 978  $ 1,049 
1 The financial information represents the results of the equity method investees during the Company’s period of ownership.
December 31, 2021 2020
Current assets $ 30,992  $ 29,431 
Noncurrent assets 72,064  67,900 
Total assets $ 103,056  $ 97,331 
Current liabilities $ 21,362  $ 20,033 
Noncurrent liabilities 37,353  33,613 
Total liabilities $ 58,715  $ 53,646 
Equity attributable to shareowners of investees $ 43,422  $ 42,622 
Equity attributable to noncontrolling interests 919  1,063 
Total equity $ 44,341  $ 43,685 
Company equity method investments $ 17,598  $ 19,273 
Net sales to equity method investees, the majority of which are located outside the United States, were $14,471 million, $13,041 million and $14,832 million in 2021, 2020 and 2019, respectively. Total payments, primarily related to marketing, made to equity method investees were $516 million, $547 million and $897 million in 2021, 2020 and 2019, respectively. The increase in net sales to equity method investees in 2021 was primarily due to recovery from the COVID-19 pandemic. In addition, purchases of beverage products from equity method investees were $496 million, $452 million and $426 million in 2021, 2020 and 2019, respectively. The increase in purchases of beverage products in 2021 was primarily due to increased purchases of Monster products as a result of international expansion and category growth.
The following table presents the difference between calculated fair value, based on quoted closing prices of publicly traded shares, and our Company’s carrying value in investments in publicly traded companies accounted for under the equity method (in millions):
December 31, 2021 Fair Value Carrying Value Difference
Monster Beverage Corporation $ 9,808  $ 4,323  $ 5,485 
Coca-Cola Europacific Partners plc 4,919  3,578  1,341 
Coca-Cola FEMSA, S.A.B. de C.V. 3,182  1,568  1,614 
Coca-Cola HBC AG 2,705  1,115  1,590 
Coca-Cola Consolidated, Inc. 1,537  224  1,313 
Coca-Cola Bottlers Japan Holdings Inc.1
387  474  (87)
Coca-Cola İçecek A.Ş. 340  123  217 
Embotelladora Andina S.A. 130  98  32 
Total $ 23,008  $ 11,503  $ 11,505 
1The carrying value of our investment in CCBJHI exceeded its fair value as of December 31, 2021 by $87 million. Based on the length of time and the extent to which the fair value has been less than our carrying value and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value, management determined that the decline in fair value was temporary in nature. Therefore, we did not record an impairment charge related to the investment.
Net Receivables and Dividends from Equity Method Investees
Total net receivables due from equity method investees were $882 million and $1,025 million as of December 31, 2021 and 2020, respectively. The total amount of dividends received from equity method investees was $823 million, $467 million and $628 million for the years ended December 31, 2021, 2020 and 2019, respectively. The amount of consolidated reinvested earnings that represents undistributed earnings of investments accounted for under the equity method as of December 31, 2021 was $6,143 million.